$CYTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTRX CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CYTRX CORP. Get notifications about new insider transactions in CYTRX CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 20 2020 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | M | 0.26 | 150,000 | 39,000 | 300,000 | |
Aug 20 2020 | CYTR | CYTRX CORP | Brien Earl W | Director | Buy | M | 0.26 | 150,000 | 39,000 | 590,247 | 440.2 K to 590.2 K (+34.07 %) |
Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | M | 0.26 | 3,000,000 | 780,000 | 0 | |
Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Payment of Exercise | F | 0.67 | 1,164,179 | 780,000 | 3,668,038 | 4.8 M to 3.7 M (-24.09 %) |
Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Buy | M | 0.26 | 3,000,000 | 780,000 | 4,832,217 | 1.8 M to 4.8 M (+163.74 %) |
Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | M | 0.26 | 700,000 | 182,000 | 0 | |
Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Payment of Exercise | F | 0.67 | 271,642 | 182,000 | 600,785 | 872.4 K to 600.8 K (-31.14 %) |
Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Buy | M | 0.26 | 700,000 | 182,000 | 872,427 | 172.4 K to 872.4 K (+405.97 %) |
Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | M | 0.26 | 450,000 | 117,000 | 0 | |
Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Payment of Exercise | F | 0.67 | 174,627 | 117,000 | 335,373 | 510 K to 335.4 K (-34.24 %) |
Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Buy | M | 0.26 | 450,000 | 117,000 | 510,000 | 60 K to 510 K (+750.00 %) |
Dec 17 2019 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Option Exercise | A | 0.26 | 3,000,000 | 780,000 | 3,000,000 | |
Dec 17 2019 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 0.26 | 700,000 | 182,000 | 700,000 | |
Dec 17 2019 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 0.26 | 350,000 | 91,000 | 350,000 | |
Dec 17 2019 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | A | 0.26 | 450,000 | 117,000 | 450,000 | |
Dec 17 2019 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | A | 0.26 | 450,000 | 117,000 | 450,000 | |
Jan 02 2018 | CYTR | CYTRX CORP | Kratz Felix | Vice President Drug ... | Option Exercise | A | 1.75 | 25,000 | 43,750 | 25,000 | |
Dec 19 2017 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 1.75 | 30,000 | 52,500 | 30,000 | |
Dec 19 2017 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 1.75 | 58,334 | 102,085 | 58,334 | |
Dec 19 2017 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | A | 1.75 | 30,000 | 52,500 | 30,000 | |
Dec 19 2017 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | A | 1.75 | 70,000 | 122,500 | 70,000 | |
Dec 19 2017 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Option Exercise | A | 1.75 | 208,334 | 364,585 | 208,334 | |
Dec 19 2017 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Grant | A | 1.75 | 387,597 | 678,295 | 387,597 | 0 to 387.6 K |
Sep 06 2017 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | A | 0.67 | 180,000 | 120,600 | 180,000 | |
Dec 20 2016 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Option Exercise | A | 0.43 | 1,250,000 | 537,500 | 1,250,000 | |
Dec 20 2016 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Grant | A | 0.43 | 2,325,581 | 1,000,000 | 2,325,581 | 0 to 2.3 M |
Dec 19 2016 | CYTR | CYTRX CORP | LEVITT DANIEL J | EVP and Chief Medic ... | Option Exercise | A | 0.43 | 400,000 | 172,000 | 400,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr VP - Drug Develo ... | Option Exercise | A | 0.43 | 150,000 | 64,500 | 150,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 0.43 | 350,000 | 150,500 | 350,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Option Exercise | A | 0.43 | 1,250,000 | 537,500 | 1,250,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 0.43 | 180,000 | 77,400 | 180,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 0.43 | 180,000 | 77,400 | 180,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | Chawla Anita J | Director | Option Exercise | A | 0.43 | 180,000 | 77,400 | 180,000 | |
Dec 19 2016 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | A | 0.43 | 180,000 | 77,400 | 180,000 | |
Dec 06 2016 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | A | 0.52 | 180,000 | 93,600 | 180,000 | |
Jan 14 2016 | CYTR | CYTRX CORP | Ware Olivia C | Chief Commercial Of ... | Option Exercise | A | 2.15 | 350,000 | 752,500 | 350,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr VP - Drug Develo ... | Option Exercise | A | 2.44 | 100,000 | 244,000 | 100,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | SELTER ERIC JAY | Director | Option Exercise | A | 2.44 | 180,000 | 439,200 | 180,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 2.44 | 180,000 | 439,200 | 180,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | Levin Ben | SVP-Legal Affairs/G ... | Option Exercise | A | 2.44 | 300,000 | 732,000 | 300,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 2.44 | 180,000 | 439,200 | 180,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | Cohen Cheryl | Director | Option Exercise | A | 2.44 | 180,000 | 439,200 | 180,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | Chawla Anita J | Director | Option Exercise | A | 2.44 | 180,000 | 439,200 | 180,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 2.44 | 300,000 | 732,000 | 300,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | LEVITT DANIEL J | EVP and Chief Medic ... | Option Exercise | A | 2.44 | 500,000 | 1,220,000 | 500,000 | |
Dec 17 2015 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO and Chairman of ... | Option Exercise | A | 2.44 | 1,000,000 | 2,440,000 | 1,000,000 | |
Dec 17 2014 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 2.15 | 200,000 | 430,000 | 200,000 | |
Dec 17 2014 | CYTR | CYTRX CORP | LEVITT DANIEL J | EVP and Chief Medic ... | Option Exercise | A | 2.15 | 400,000 | 860,000 | 400,000 | |
Dec 17 2014 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr VP - Drug Develo ... | Option Exercise | A | 2.15 | 200,000 | 430,000 | 200,000 | |
Dec 17 2014 | CYTR | CYTRX CORP | Levin Ben | GC/SVP-Legal Affair ... | Option Exercise | A | 2.15 | 200,000 | 430,000 | 200,000 | |
Dec 16 2014 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | President, CEO, Boa ... | Option Exercise | A | 2.15 | 600,000 | 1,290,000 | 600,000 | |
Dec 16 2014 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Option Exercise | A | 2.15 | 180,000 | 387,000 | 180,000 | |
Dec 16 2014 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 2.15 | 180,000 | 387,000 | 180,000 | |
Dec 16 2014 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 2.15 | 180,000 | 387,000 | 180,000 | |
Jan 03 2014 | CYTR | CYTRX CORP | LEVITT DANIEL J | EVP and Chief Medic ... | Grant | A | 0.00 | 100,000 | 0 | 214,286 | 114.3 K to 214.3 K (+87.50 %) |
Dec 12 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Sell | P | 2.40 | 334,979 | 805,256 | 4,577,605 | 4.9 M to 4.6 M (-6.82 %) |
Dec 12 2013 | CYTR | CYTRX CORP | Levin Ben | GC/SVP Legal Affair ... | Option Exercise | A | 2.39 | 300,000 | 717,000 | 300,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 2.39 | 180,000 | 430,200 | 0 | |
Dec 12 2013 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | A | 2.39 | 180,000 | 430,200 | 180,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | LEVITT DANIEL J | EVP and Chief Medic ... | Option Exercise | A | 2.39 | 500,000 | 1,195,000 | 500,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 2.39 | 180,000 | 430,200 | 180,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Option Exercise | A | 2.39 | 180,000 | 430,200 | 180,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 2.39 | 180,000 | 430,200 | 180,000 | |
Dec 11 2013 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | A | 2.39 | 925,000 | 2,210,750 | 925,000 | |
Dec 12 2013 | CYTR | CYTRX CORP | LINK MAX | Director | Option Exercise | A | 2.39 | 180,000 | 430,200 | 180,000 | |
Dec 03 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.35 | 42,131 | 98,907 | 4,912,584 | 4.9 M to 4.9 M (+0.87 %) |
Dec 03 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.39 | 77,148 | 184,461 | 4,870,453 | 4.8 M to 4.9 M (+1.61 %) |
Dec 03 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.48 | 165,700 | 411,151 | 4,793,305 | 4.6 M to 4.8 M (+3.58 %) |
Dec 11 2013 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr. VP - Drug Devel ... | Option Exercise | A | 2.39 | 150,000 | 358,500 | 150,000 | |
Dec 11 2013 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 2.39 | 150,000 | 358,500 | 150,000 | |
Nov 08 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.06 | 50,000 | 102,840 | 4,627,605 | 4.6 M to 4.6 M (+1.09 %) |
Apr 03 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.70 | 4,083 | 11,024 | 4,577,605 | 4.6 M to 4.6 M (+0.09 %) |
Mar 22 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.61 | 3,980 | 10,388 | 4,573,522 | 4.6 M to 4.6 M (+0.09 %) |
Mar 20 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.57 | 8,420 | 21,643 | 4,569,542 | 4.6 M to 4.6 M (+0.18 %) |
Mar 20 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.58 | 24,100 | 62,166 | 4,561,122 | 4.5 M to 4.6 M (+0.53 %) |
Mar 20 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.56 | 3,000 | 7,667 | 4,537,022 | 4.5 M to 4.5 M (+0.07 %) |
Mar 14 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.52 | 360 | 907 | 4,534,022 | 4.5 M to 4.5 M (+0.01 %) |
Mar 14 2013 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.67 | 55,000 | 146,740 | 4,533,662 | 4.5 M to 4.5 M (+1.23 %) |
Mar 12 2013 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | A | 2.46 | 74,176 | 182,473 | 74,176 | |
Jan 02 2013 | CYTR | CYTRX CORP | LEVITT DANIEL J | Chief Medical Offic ... | Grant | A | 0.00 | 100,000 | 0 | 200,000 | 100 K to 200 K (+100.00 %) |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 2.80 | 7,142 | 19,998 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 5.04 | 7,142 | 35,996 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 5.46 | 7,142 | 38,995 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 8.05 | 7,142 | 57,493 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 3.99 | 3,572 | 14,252 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 23.31 | 3,572 | 83,263 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 7.77 | 3,572 | 27,754 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 5.88 | 2,142 | 12,595 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 8.33 | 714 | 5,948 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 8.40 | 1,428 | 11,995 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 16.45 | 1,428 | 23,491 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | G | 1.83 | 100,000 | 183,000 | 0 | |
Dec 11 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 1.83 | 30,000 | 54,900 | 30,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | LINK MAX | Director | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr. VP - Drug Devel ... | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | A | 1.83 | 500,000 | 915,000 | 500,000 | |
Dec 11 2012 | CYTR | CYTRX CORP | Levin Ben | GC/VP Legal Affairs ... | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Oct 23 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.51 | 115,000 | 288,328 | 4,478,662 | 4.4 M to 4.5 M (+2.64 %) |
Oct 23 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.51 | 65,000 | 163,339 | 4,363,662 | 4.3 M to 4.4 M (+1.51 %) |
Oct 18 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 2.50 | 1,200,000 | 3,000,000 | 4,298,662 | 3.1 M to 4.3 M (+38.73 %) |
Jun 28 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.90 | 16,000 | 78,432 | 3,098,662 | 3.1 M to 3.1 M (+0.52 %) |
Jun 28 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 5.23 | 15,824 | 82,785 | 3,082,662 | 3.1 M to 3.1 M (+0.52 %) |
Jun 28 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 5.32 | 13,000 | 69,128 | 3,066,838 | 3.1 M to 3.1 M (+0.43 %) |
Jun 25 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 5.16 | 17,835 | 92,089 | 3,053,838 | 3 M to 3.1 M (+0.59 %) |
Jun 25 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.74 | 5,334 | 25,289 | 3,036,003 | 3 M to 3 M (+0.18 %) |
Jun 25 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.61 | 4,293 | 19,795 | 3,030,669 | 3 M to 3 M (+0.14 %) |
Jun 18 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.89 | 3,558 | 13,850 | 3,005,262 | 3 M to 3 M (+0.12 %) |
Jun 18 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.83 | 10,976 | 42,063 | 3,001,704 | 3 M to 3 M (+0.37 %) |
Jun 20 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.65 | 7,283 | 33,848 | 3,026,376 | 3 M to 3 M (+0.24 %) |
Jun 20 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.48 | 9,210 | 41,257 | 3,019,093 | 3 M to 3 M (+0.31 %) |
Jun 20 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 4.25 | 4,621 | 19,625 | 3,009,883 | 3 M to 3 M (+0.15 %) |
Jun 14 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.88 | 14,176 | 55,027 | 2,990,728 | 3 M to 3 M (+0.48 %) |
Jun 14 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.80 | 5,594 | 21,266 | 2,976,552 | 3 M to 3 M (+0.19 %) |
Jun 12 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.80 | 23,399 | 89,014 | 2,970,958 | 2.9 M to 3 M (+0.79 %) |
Jun 12 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.80 | 20,933 | 79,566 | 2,947,559 | 2.9 M to 2.9 M (+0.72 %) |
Jun 07 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.85 | 53,635 | 206,264 | 2,926,626 | 2.9 M to 2.9 M (+1.87 %) |
Jun 07 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.97 | 24,894 | 98,727 | 2,872,991 | 2.8 M to 2.9 M (+0.87 %) |
Jun 07 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.85 | 66,704 | 256,897 | 2,848,097 | 2.8 M to 2.8 M (+2.40 %) |
Jun 04 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.53 | 221,000 | 779,113 | 2,863,292 | 2.6 M to 2.9 M (+8.36 %) |
Jun 04 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.74 | 86,696 | 323,931 | 2,642,292 | 2.6 M to 2.6 M (+3.39 %) |
Jun 04 2012 | CYTR | CYTRX CORP | Patterson Scott Bradford | 10% Owner | Buy | P | 3.83 | 190,200 | 728,922 | 2,555,596 | 2.4 M to 2.6 M (+8.04 %) |
May 15 2012 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
May 15 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
May 15 2012 | CYTR | CYTRX CORP | RUBINFELD JOSEPH | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
May 15 2012 | CYTR | CYTRX CORP | LINK MAX | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
May 15 2012 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
Feb 24 2012 | CYTR | CYTRX CORP | LINK MAX | Director | Buy | P | 0.33 | 136,540 | 44,580 | 260,305 | 123.8 K to 260.3 K (+110.32 %) |
Feb 24 2012 | CYTR | CYTRX CORP | LINK MAX | Director | Buy | P | 0.31 | 68,789 | 21,276 | 123,765 | 55 K to 123.8 K (+125.13 %) |
Feb 24 2012 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Buy | P | 0.33 | 21,141 | 6,903 | 31,792 | 10.7 K to 31.8 K (+198.49 %) |
Feb 24 2012 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Buy | P | 0.31 | 10,651 | 3,294 | 10,651 | 0 to 10.7 K |
Feb 24 2012 | CYTR | CYTRX CORP | SELTER MARVIN R | Director | Buy | P | 0.31 | 100,000 | 31,200 | 253,193 | 153.2 K to 253.2 K (+65.28 %) |
Feb 24 2012 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Buy | P | 0.33 | 74,455 | 24,310 | 116,965 | 42.5 K to 117 K (+175.15 %) |
Feb 24 2012 | CYTR | CYTRX CORP | Wennekamp Richard L. | Director | Buy | P | 0.31 | 37,510 | 11,602 | 42,510 | 5 K to 42.5 K (+750.20 %) |
Feb 24 2012 | CYTR | CYTRX CORP | LEVITT DANIEL J | Chief Medical Offic ... | Buy | P | 0.29 | 100,000 | 28,750 | 100,000 | 0 to 100 K |
Feb 24 2012 | CYTR | CYTRX CORP | Levin Ben | GC/VP Legal Affairs ... | Buy | P | 0.33 | 22,329 | 7,290 | 33,578 | 11.2 K to 33.6 K (+198.50 %) |
Feb 24 2012 | CYTR | CYTRX CORP | Levin Ben | GC/VP Legal Affairs ... | Buy | P | 0.31 | 11,249 | 3,479 | 11,249 | 0 to 11.2 K |
Feb 24 2012 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Buy | P | 0.33 | 105,517 | 34,451 | 4,179,776 | 4.1 M to 4.2 M (+2.59 %) |
Feb 24 2012 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Buy | P | 0.31 | 53,159 | 16,442 | 4,074,259 | 4 M to 4.1 M (+1.32 %) |
Dec 14 2011 | CYTR | CYTRX CORP | LEVITT DANIEL J | Chief Medical Offic ... | Option Exercise | A | 0.31 | 500,000 | 155,000 | 500,000 | |
Dec 13 2011 | CYTR | CYTRX CORP | Levin Ben | GC/VP Legal Affairs ... | Option Exercise | A | 0.31 | 250,000 | 77,500 | 250,000 | |
Dec 13 2011 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 0.31 | 200,000 | 62,000 | 200,000 | |
Dec 13 2011 | CYTR | CYTRX CORP | Geyer David Scott | Sr. V.P. of Manufac ... | Option Exercise | A | 0.31 | 200,000 | 62,000 | 200,000 | |
Dec 13 2011 | CYTR | CYTRX CORP | Wieland Douglas Scott | Sr,VP - Drug Develo ... | Option Exercise | A | 0.31 | 200,000 | 62,000 | 200,000 | |
Dec 13 2011 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | A | 0.31 | 1,500,000 | 465,000 | 1,500,000 | |
Jul 01 2011 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 0.72 | 50,000 | 36,000 | 50,000 |